Search Results - "Olfe'rev, A M"

Refine Results
  1. 1

    Association of serum apolipoprotein A-II concentration with combined hyperlipidemia and impaired glucose tolerance by Aleksandrovich, O V, Ozerova, I N, Olfer'ev, A M, Serdyuk, A P, Metel'skaya, V A, Perova, N V

    “…We studied the relationship of serum apolipoprotein A-II concentration with biochemical parameters of lipid and carbohydrate metabolism, type of…”
    Get full text
    Journal Article
  2. 2

    Oxidation of plasma low-density lipoproteins from coronary patients with various forms of hypercholesterolemia by Lankin, V Z, Konovalova, G G, Tikhaze, A K, Nezhdanova, I B, Olfer'ev, A M, Kukharchuk, V V

    “…The duration of lag-phase of copper-induced free-radical oxidation of atherogenic LDL isolated from the plasma of coronary patients without…”
    Get full text
    Journal Article
  3. 3

    Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia by Perova, N V, Ozerova, I N, Paramonova, I V, Olfer'ev, A M, Akhmedzhanov, N M, Pavlova, L I, Oganov, R G

    “…We studied phospholipid composition of high-density lipoproteins in patients with normo- and hypertriglyceridemia treated with various hypolipidemic…”
    Get full text
    Journal Article
  4. 4

    Development of a model system for evaluation of human endothelial cell proliferation in vitro: possible clinical applications by Koval'chuk, N V, Petrichenko, I E, Olfer'ev, A M, Shchukina, G N, Popkov, S A, Metel'skaya, V A

    “…A system for evaluation of the ability of human blood serum to affect endothelial cell proliferation was developed and tested. The system based on…”
    Get full text
    Journal Article
  5. 5

    Effect of micronized fenofibrate (Lipanthyl-200M) on cholesterol synthesis in peripheral blood lymphocytes in hyperlipidemic patients with coronary heart disease by Ivanova, T. N., Polyakova, E. D., Olfer'ev, A. M., Perova, N. V.

    “…The rate of cholesterol synthesis in peripheral blood lymphocytes and plasma lipid and lipoprotein spectra are studied in patients with isolated…”
    Get full text
    Journal Article
  6. 6

    Primary prevention of cardiovascular diseases: long term results of five year long preventive intervention in 12-year old boys (ten year prospective study) by Rozanov, V B, Aleksandov, A A, Shugaeva, E N, Perova, N V, Maslennikova, G Ia, Smirnova, S G, Olfer'ev, A M

    Published in Kardiologiia (2007)
    “…In a longitudinal cohort (prevention group, n=213, comparison group, n=163) of 10-year prospective follow-up we addressed efficacy of 5-year-long multifactor…”
    Get more information
    Journal Article
  7. 7

    Effect of lycopene on blood lipoproteids in women with type 2 diabetes mellitus in postmenopause by Olfer'ev, A M, Il'ina, M V, Berzak, N V, Stetsenko, A V, Olfer'ev, M A, Chudakova, I A, Kapitanov, A B, Shamarin, V M

    Published in Voprosy pitaniia (2004)
    “…Blind randomized placebo-control research included 39 women. The following criteria were: menopause period for more then 1 year long; diabetes mellitus;…”
    Get more information
    Journal Article
  8. 8

    Development of a model system for evaluation of human endothelial cell proliferationin Vitro: Possible clinical applications by Koval'chuk, N. V., Petrichenko, I. E., Olfer'ev, A. M., Shchukina, G. N., Popkov, S. A., Metel'skaya, V. A.

    “…A system for evaluation of the ability of human blood serum to affect endothelial cell proliferation was developed and tested. The system based on…”
    Get full text
    Journal Article
  9. 9

    Effects of simvastatin on the phospholipid composition of high-density lipoproteins in patients with hypercholesterolemia by Ozerova, I N, Paramonova, I V, Olfer'ev, A M, Akhmedzhanov, N M, Aleksandrova, M A, Perova, N V

    “…We studied the phospholipid composition of high-density lipoproteins in patients with hypercholesterolemia before and after treatment with simvastatin…”
    Get full text
    Journal Article
  10. 10

    Design of constructions for the expression of proteolytic antibody light chain by Demin, A V, Kolesnikov, A V, Olfer'ev, M A, Favorov, P V, Fegeding, K V, Gabibov, A G, Gnuchev, N V

    Published in Genetika (01-10-1998)
    “…A new system for the expression of a catalytic light chain antibody to the vasoactive intestinal peptide is described. The system made possible the isolation…”
    Get more information
    Journal Article
  11. 11

    Factors determining arterial blood pressure in childhood by Rozanov, V B, Aleksandrov, A A, Olfer'ev, A M, Maslova, E R, Barsov, D A

    Published in Cor et vasa (English ed.) (1990)
    “…As part of a programme designed to determine precursors of arterial hypertension and atherosclerosis in children and adolescents, a cross-sectional study…”
    Get more information
    Journal Article
  12. 12

    Characteristics of the blood serum lipoprotein pattern in female Tallinn residents aged 35-54 years by Olfeŕev, A M, Volozh, O I, Sokolova, M A, Chudakova, I A, Gal'perina, T N, Solodkaya, E S, Tagger, Yu Kh

    Published in Cor et vasa (English ed.) (1991)
    “…In a single study of the female population aged 35-54 years in the city of Tallinn no significant differences in the blood lipoprotein pattern for the…”
    Get more information
    Journal Article
  13. 13

    Characteristics of the plasma lipid profile in the male population of Tallinn aged 20-54 years by Olfer'ev, A M, Volozh, O I, Polesskii, V A, Sokolova, M A, Chudakova, I A, Pauts, V M, Solodkaya, E S

    Published in Cor et vasa (English ed.) (1990)
    “…The blood plasma lipoprotein profile was studied in a representative random sample of the male population in Tallinn, comprising 2292 men aged 20-54 years…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16

    Monoclonal antibody therapy with mabtera of patients with b-cell low grade non-Hodgkin's lymphoma by Karchenko, V P, Voznyĭ, E K, Belonogov, A V, Bozhenko, V K, Olfer'ev, M A, Galil-Ogly, G A

    Published in Voprosy onkologij (2005)
    “…The data on monoclonal antibody monotherapy (mabtera, rituximab) in 44 patients with B-cell low grade non-Hodgkin's lymphoma were assessed. Thirty-four of them…”
    Get more information
    Journal Article
  17. 17

    Atherogenic dyslipidemia in adolescents: its relation to ischemic heart disease in their fathers and the possibility of its prognosis by Mete'lskaia, V A, Aĭngorn, E D, Maslennikova, G Ia, Dorofeeva, T G, Gorchakova, N N, Sipiagina, A E, Ruzhanskaia, T V, Grigo'reva, I V, Olfe'rev, A M, Beloko'n, N A

    Published in Kardiologiia (01-09-1989)
    “…Comparison of a group of adolescents aged 11-16 years whose fathers had angiographically documented coronary atherosclerosis in youth with those matched by sex…”
    Get more information
    Journal Article
  18. 18

    Signs of metabolic syndrome in combinations of hypertension with coronary risk factors by Oganov, R G, Perova, N V, Shchel'tsyna, N V, Ozerova, I N, Olfer'ev, A M, Mamedov, M N, Mel'kina, O E, Metel'skaia, V A

    Published in Kardiologiia (2005)
    “…Anthropometric data, parameters of lipoprotein spectrum and carbohydrate metabolism were obtained from 115 men aged 34-67 years with hypertension. Hypertension…”
    Get more information
    Journal Article
  19. 19

    Prevalence of dyslipidemia in open population of Tiumen by Akimova, E V, Dracheva, L V, Gakova, E I, Zhuravleva, T D, Olfer'ev, A M, Gafarov, V V, Kuznetsov, V A

    Published in Terapevtic̆eskii arhiv (2004)
    “…To evaluate levels of total cholesterol (TC), HDLP cholesterol, triglycerides (TG), occurrence of hypercholesterolemia (HCE), hypertriglyceridemia (HTG) and…”
    Get more information
    Journal Article
  20. 20

    X chromosome inactivation pattern in elderly women over 70 years of age by Iurov, I Iu, Willard, L, Vorsanova, S G, Demidova, I A, Goĭko, E A, Shal'nova, S A, Shkol'nikova, M A, Olfer'ev, A M, Iurov, Iu B

    Published in TSitologiia i genetika (01-07-2004)
    “…In the present study we have analyzed X chromosome inactivation patterns in 40 women aged from 74 to 85 years (mean age 78 years). The control group was 36…”
    Get more information
    Journal Article